Clinical Feature of Intrahepatic B-Lymphocytes in Chronic Hepatitis B

Humoral immunity constitutes major defense mechanism against viral infections. However, the association of hepatic injury and B-cells population in chronic hepatitis B virus (HBV) carriers has not been studied well. In this study, fifty seven hepatitis B surface antigen (HBsAg) positive and HBeAg ne...

Full description

Saved in:
Bibliographic Details
Main Authors: Ashraf Mohamadkhani, Elnaz Naderi, Masoud Sotoudeh, Aezam Katoonizadeh, Ghodratollah Montazeri, Hossein Poustchi
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:International Journal of Inflammation
Online Access:http://dx.doi.org/10.1155/2014/896864
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564188536373248
author Ashraf Mohamadkhani
Elnaz Naderi
Masoud Sotoudeh
Aezam Katoonizadeh
Ghodratollah Montazeri
Hossein Poustchi
author_facet Ashraf Mohamadkhani
Elnaz Naderi
Masoud Sotoudeh
Aezam Katoonizadeh
Ghodratollah Montazeri
Hossein Poustchi
author_sort Ashraf Mohamadkhani
collection DOAJ
description Humoral immunity constitutes major defense mechanism against viral infections. However, the association of hepatic injury and B-cells population in chronic hepatitis B virus (HBV) carriers has not been studied well. In this study, fifty seven hepatitis B surface antigen (HBsAg) positive and HBeAg negative patients were studied to determine the expression of CD20, a cell surface marker expressed on B-cells, in liver biopsy sections using immunohistochemistry. The patients’ clinical data at the time of liver biopsy were acquired from their medical records. There was a significant association between log HBV DNA and both ALT (r=0.36, P=0.006) and histologic activity index (HAI) total score (r=0.3, P=0.02), respectively. The CD20 was expressed in all 57 liver biopsy samples with a submembranous and membranous staining pattern and its expression was significantly associated with HAI total score (r=0.32, P=0.01) and stage of fibrosis (r=0.31, P=0.02). The susceptible B lymphocytes to hepatitis B virus might be implicated in the development of immune mediated inflammation of HBV-induced hepatic injury. The present data also support that the liver is potentially one of the secondary lymphoid organs.
format Article
id doaj-art-4d375a36e6b34dfcaaff482e98a15831
institution Kabale University
issn 2090-8040
2042-0099
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series International Journal of Inflammation
spelling doaj-art-4d375a36e6b34dfcaaff482e98a158312025-02-03T01:11:34ZengWileyInternational Journal of Inflammation2090-80402042-00992014-01-01201410.1155/2014/896864896864Clinical Feature of Intrahepatic B-Lymphocytes in Chronic Hepatitis BAshraf Mohamadkhani0Elnaz Naderi1Masoud Sotoudeh2Aezam Katoonizadeh3Ghodratollah Montazeri4Hossein Poustchi5Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Centre, Tehran University of Medical Sciences, Shariati Hospital, North Kargar Avenue, Tehran 14117 13135, IranLiver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Centre, Tehran University of Medical Sciences, Shariati Hospital, North Kargar Avenue, Tehran 14117 13135, IranLiver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Centre, Tehran University of Medical Sciences, Shariati Hospital, North Kargar Avenue, Tehran 14117 13135, IranLiver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Centre, Tehran University of Medical Sciences, Shariati Hospital, North Kargar Avenue, Tehran 14117 13135, IranLiver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Centre, Tehran University of Medical Sciences, Shariati Hospital, North Kargar Avenue, Tehran 14117 13135, IranLiver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Centre, Tehran University of Medical Sciences, Shariati Hospital, North Kargar Avenue, Tehran 14117 13135, IranHumoral immunity constitutes major defense mechanism against viral infections. However, the association of hepatic injury and B-cells population in chronic hepatitis B virus (HBV) carriers has not been studied well. In this study, fifty seven hepatitis B surface antigen (HBsAg) positive and HBeAg negative patients were studied to determine the expression of CD20, a cell surface marker expressed on B-cells, in liver biopsy sections using immunohistochemistry. The patients’ clinical data at the time of liver biopsy were acquired from their medical records. There was a significant association between log HBV DNA and both ALT (r=0.36, P=0.006) and histologic activity index (HAI) total score (r=0.3, P=0.02), respectively. The CD20 was expressed in all 57 liver biopsy samples with a submembranous and membranous staining pattern and its expression was significantly associated with HAI total score (r=0.32, P=0.01) and stage of fibrosis (r=0.31, P=0.02). The susceptible B lymphocytes to hepatitis B virus might be implicated in the development of immune mediated inflammation of HBV-induced hepatic injury. The present data also support that the liver is potentially one of the secondary lymphoid organs.http://dx.doi.org/10.1155/2014/896864
spellingShingle Ashraf Mohamadkhani
Elnaz Naderi
Masoud Sotoudeh
Aezam Katoonizadeh
Ghodratollah Montazeri
Hossein Poustchi
Clinical Feature of Intrahepatic B-Lymphocytes in Chronic Hepatitis B
International Journal of Inflammation
title Clinical Feature of Intrahepatic B-Lymphocytes in Chronic Hepatitis B
title_full Clinical Feature of Intrahepatic B-Lymphocytes in Chronic Hepatitis B
title_fullStr Clinical Feature of Intrahepatic B-Lymphocytes in Chronic Hepatitis B
title_full_unstemmed Clinical Feature of Intrahepatic B-Lymphocytes in Chronic Hepatitis B
title_short Clinical Feature of Intrahepatic B-Lymphocytes in Chronic Hepatitis B
title_sort clinical feature of intrahepatic b lymphocytes in chronic hepatitis b
url http://dx.doi.org/10.1155/2014/896864
work_keys_str_mv AT ashrafmohamadkhani clinicalfeatureofintrahepaticblymphocytesinchronichepatitisb
AT elnaznaderi clinicalfeatureofintrahepaticblymphocytesinchronichepatitisb
AT masoudsotoudeh clinicalfeatureofintrahepaticblymphocytesinchronichepatitisb
AT aezamkatoonizadeh clinicalfeatureofintrahepaticblymphocytesinchronichepatitisb
AT ghodratollahmontazeri clinicalfeatureofintrahepaticblymphocytesinchronichepatitisb
AT hosseinpoustchi clinicalfeatureofintrahepaticblymphocytesinchronichepatitisb